ArticleOncology and therapy2025

Abemaciclib Persistence in Patients with HR+, HER2-, Node-Positive Early Breast Cancer: a Real-World Analysis.

Kathryn Hudson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.